ReviewFrontiers in pharmacology2024

Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review.

Angelika Buczyńska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.